EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR genome editing advances against gastric cancer

Mengmeng Zhang, Qihang Su, Qian Zhang, Xianguang Yang

Exploration of Digestive Diseases · 2025

DOI: 10.37349/edd.2025.1005106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Digestive Diseases, 2025. Verfasst von Mengmeng Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is one of the most common malignant tumors, ranking fifth in incidence and third in mortality worldwide. China also bears a high burden of GC, second only to lung cancer. With the advancement of clustered regularly interspaced short palindromic repeats (CRISPR) technology, the mechanisms underlying the development and progression of various tumor types have been elucidated. This article summarizes the application of CRISPR technology in the functional genomics identification and target screening of GC genes, explores the use of chimeric antigen receptor T (CAR-T) cell therapy for solid gastric tumors, and discusses the progress and significance of CRISPR technology in constructing GC models using organoids.

Zitieren

APA

Zhang, M., Su, Q., Zhang, Q., & Yang, X. (2025). CRISPR genome editing advances against gastric cancer. Exploration of Digestive Diseases. https://doi.org/10.37349/edd.2025.1005106

Vancouver

Zhang M, Su Q, Zhang Q, Yang X. CRISPR genome editing advances against gastric cancer. Exploration of Digestive Diseases. 2025. doi:10.37349/edd.2025.1005106

BibTeX
@article{Zhang2025,
  author = {Zhang, Mengmeng and Su, Qihang and Zhang, Qian and Yang, Xianguang},
  title = {CRISPR genome editing advances against gastric cancer},
  journal = {Exploration of Digestive Diseases},
  year = {2025},
  doi = {10.37349/edd.2025.1005106}
}
Kostenlos starten →